Page 7 - FPGEE Management Q&A Book

www.pharmacyexam.com Krisman

QUESTIONS

1. For two drug products to be considered 4. Current DUR procedure in most health plans
bioequivalent: usually focuses on:

I. The rate of absorption between the products shall I. Product-centered DUR study.
differ by -20% or +25% or less. II. Patient-centered DUR study.
III. Healthcare system-centered DUR study.
II. The 90% confidence interval for the ratio of the
mean response shall be within the limits of 0.8 and a. I only
1.25. b. I and II only
c. II and III only
III. The extent of absorption between the products d. All
shall differ by -20% or +25% or less.
5.Which of the following is/are TRUE about the
a. I only Medicare Advantage Plan?
b. I and II only
c. II and III only I. The Medicare Advantage plan includes HMOs
d. All offering prescription drug coverage.

2. A prescription for Lorazepam issued on II. The Medicare Advantage plan includes PPOs
01/01/2021 should not be filled after: offering prescription drug coverage.

a. 04/01/2021. III. The Medicare Advantage plan was formerly
b. 07/01/2021. known as Medicare + Choice.
c. 10/01/2021.
d. 01/01/2022. a. I only
b. I and II only
3. Which of the following statements is/are TRUE c. II and III only
ABOUT physician assistants (PAs)? d. All

I. PAs are healthcare professionals licensed to 6. The Medicare Part D prescription drug benefit
practice medicine under the physician’s supervision. program was enacted as part of the Medicare
Prescription Drug under the:
II. PAs are allowed to write prescriptions.
a. DBA.
III. PAs are educated in the medical model designed b. OBRA.
to complement physician training. c. MCA.
d. MMA.
a. I only
b. I and II only 7. Which of the following factors is the most
c. II and III only responsible for lower medication adherence rates in
d. All blood-glucose lowering therapy?

a. Medication side effects
b. Frequent dosing
c. Lack of perceived regimen benefits
d. Medication costs

5